Insmed, Inc. (INSM)
163.60
+1.17
(+0.72%)
USD |
NASDAQ |
Apr 06, 14:34
Insmed SG&A Expense (TTM) : 701.17M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 813.83M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| PTC Therapeutics, Inc. | 347.14M |
| Revolution Medicines, Inc. | 195.04M |
| Amicus Therapeutics, Inc. | 383.49M |